Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Seminars in Oncology
|
March 20, 2003
Studies with ZD1839 in preclinical models
Francis M Sirotnak
Acta Biochimica Polonica
|
June 15, 2017
E2F site in the essential promoter region does not confer S phase-specific transcription of the ABCC10 gene in human prostate cancer cells
Magdalena Dabrowska, Francis M Sirotnak
Gene
|
October 12, 2004
Regulation of transcription of the human MRP7 gene. Characteristics of the basal promoter and identification of tumor-derived transcripts encoding additional 5' end heterogeneity
Magdalena Dabrowska, Francis M Sirotnak
Cancer Research
|
July 19, 2002
Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells
Monica Motwani, Francis M Sirotnak, Yuhong She, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2002
Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer
Francis M Sirotnak, Yohung She, Fei Lee, et al.
Biochemical and Biophysical Research Communications
|
November 26, 2003
A new human peptide deformylase inhibitable by actinonin
Mona D Lee, Christophe Antczak, Yueming Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2003
The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells
Christoph Jung, Monica Motwani, Jeremy Kortmansky, et al.
The Journal of Clinical Investigation
|
October 19, 2004
Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics
Mona D Lee, Yuhong She, Michael J Soskis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer
Gregory J Riely, Naiyer A Rizvi, Mark G Kris, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Seminars in Oncology
|
March 20, 2003
Studies with ZD1839 in preclinical models
Francis M Sirotnak
Acta Biochimica Polonica
|
June 15, 2017
E2F site in the essential promoter region does not confer S phase-specific transcription of the ABCC10 gene in human prostate cancer cells
Magdalena Dabrowska, Francis M Sirotnak
Gene
|
October 12, 2004
Regulation of transcription of the human MRP7 gene. Characteristics of the basal promoter and identification of tumor-derived transcripts encoding additional 5' end heterogeneity
Magdalena Dabrowska, Francis M Sirotnak
Cancer Research
|
July 19, 2002
Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells
Monica Motwani, Francis M Sirotnak, Yuhong She, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2002
Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer
Francis M Sirotnak, Yohung She, Fei Lee, et al.
Biochemical and Biophysical Research Communications
|
November 26, 2003
A new human peptide deformylase inhibitable by actinonin
Mona D Lee, Christophe Antczak, Yueming Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2003
The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells
Christoph Jung, Monica Motwani, Jeremy Kortmansky, et al.
The Journal of Clinical Investigation
|
October 19, 2004
Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics
Mona D Lee, Yuhong She, Michael J Soskis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer
Gregory J Riely, Naiyer A Rizvi, Mark G Kris, et al.
Page
of 1